Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Director
-
Stock Symbol
-
APLS on Nasdaq
Sinclair Dunlop - trading volume in the past year for Apellis Pharmaceuticals, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
158K |
$2.19M |
$13.85 |
Jan 1, 2025 |
Direct |
|
|
| Common Stock |
100K |
$1.39M |
$13.85 |
Jan 1, 2025 |
Indirect Owner (Epidarex) |
|
|
| Stock Option (Right to Buy) |
11.2K |
$0 |
$66.30 |
Jan 1, 2025 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.